PMC:7243768 / 27329-30999
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1054 | 5-15 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1055 | 18-31 | Disease | denotes | heart disease | MESH:D006331 |
1072 | 32-36 | Gene | denotes | ACE2 | Gene:59272 |
1073 | 200-204 | Gene | denotes | ACE2 | Gene:59272 |
1074 | 281-285 | Gene | denotes | ACE2 | Gene:59272 |
1075 | 232-242 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1076 | 487-495 | Species | denotes | patients | Tax:9606 |
1077 | 571-579 | Species | denotes | patients | Tax:9606 |
1078 | 861-869 | Species | denotes | patients | Tax:9606 |
1079 | 159-171 | Disease | denotes | hypertension | MESH:D006973 |
1080 | 176-192 | Disease | denotes | type II diabetes | MESH:D003924 |
1081 | 402-422 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
1082 | 433-445 | Disease | denotes | hypertensive | MESH:D006973 |
1083 | 562-570 | Disease | denotes | COVID-19 | MESH:C000657245 |
1084 | 599-611 | Disease | denotes | hypertension | MESH:D006973 |
1085 | 706-718 | Disease | denotes | hypertensive | MESH:D006973 |
1086 | 832-847 | Disease | denotes | viral infection | MESH:D001102 |
1087 | 900-908 | Disease | denotes | infected | MESH:D007239 |
1099 | 1009-1013 | Gene | denotes | ACE2 | Gene:59272 |
1100 | 993-1003 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1101 | 1173-1183 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1102 | 1225-1233 | Species | denotes | SARS-CoV | Tax:694009 |
1103 | 1235-1243 | Species | denotes | SARS-CoV | Tax:694009 |
1104 | 1350-1360 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1105 | 1540-1548 | Species | denotes | patients | Tax:9606 |
1106 | 1070-1082 | Disease | denotes | heart injury | MESH:D006335 |
1107 | 1258-1279 | Disease | denotes | cardiovascular damage | MESH:D002318 |
1108 | 1456-1479 | Disease | denotes | acute coronary syndrome | MESH:D054058 |
1109 | 1563-1571 | Disease | denotes | COVID-19 | MESH:C000657245 |
1143 | 1588-1592 | Gene | denotes | ACE2 | Gene:59272 |
1144 | 1867-1870 | Gene | denotes | ACE | Gene:1636 |
1145 | 1943-1957 | Gene | denotes | angiotensin II | Gene:183 |
1146 | 1999-2003 | Gene | denotes | ACE2 | Gene:59272 |
1147 | 2022-2052 | Gene | denotes | angiotensin II type 1 receptor | Gene:185 |
1148 | 2073-2083 | Gene | denotes | profilin-1 | Gene:5216 |
1149 | 2099-2103 | Gene | denotes | ACE2 | Gene:59272 |
1150 | 2131-2145 | Gene | denotes | angiotensin II | Gene:183 |
1151 | 2200-2204 | Gene | denotes | ACE2 | Gene:59272 |
1152 | 2325-2329 | Gene | denotes | ACE2 | Gene:59272 |
1153 | 2338-2342 | Gene | denotes | ACE2 | Gene:59272 |
1154 | 2367-2370 | Gene | denotes | ACE | Gene:1636 |
1155 | 2403-2417 | Gene | denotes | angiotensin II | Gene:183 |
1156 | 2546-2550 | Gene | denotes | ACE2 | Gene:59272 |
1157 | 2597-2601 | Gene | denotes | ACE2 | Gene:59272 |
1158 | 2651-2655 | Gene | denotes | ACE2 | Gene:59272 |
1159 | 2703-2707 | Gene | denotes | ACE2 | Gene:59272 |
1160 | 2726-2729 | Gene | denotes | ACE | Gene:1636 |
1161 | 2929-2959 | Gene | denotes | angiotensin II type 1 receptor | Gene:185 |
1162 | 2527-2541 | Gene | denotes | angiotensin II | Gene:183 |
1163 | 1631-1639 | Species | denotes | patients | Tax:9606 |
1164 | 1654-1664 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1165 | 2557-2567 | Species | denotes | SARS-CoV 2 | Tax:2697049 |
1166 | 2275-2285 | Chemical | denotes | lisinopril | MESH:D017706 |
1167 | 2290-2298 | Chemical | denotes | losartan | MESH:D019808 |
1168 | 1640-1648 | Disease | denotes | infected | MESH:D007239 |
1169 | 1686-1701 | Disease | denotes | cardiac failure | MESH:D006333 |
1170 | 2830-2837 | Disease | denotes | atrophy | MESH:D001284 |
1171 | 2845-2853 | Disease | denotes | fibrosis | MESH:D005355 |
1172 | 2860-2872 | Disease | denotes | inflammation | MESH:D007249 |
1173 | 2971-2978 | Disease | denotes | atrophy | MESH:D001284 |
1174 | 2984-2992 | Disease | denotes | fibrosis | MESH:D005355 |
1175 | 2998-3010 | Disease | denotes | inflammation | MESH:D007249 |
1185 | 3411-3415 | Gene | denotes | ACE2 | Gene:59272 |
1186 | 3532-3537 | Gene | denotes | renin | Gene:5972 |
1187 | 3370-3375 | Gene | denotes | renin | Gene:5972 |
1188 | 3258-3266 | Species | denotes | patients | Tax:9606 |
1189 | 3637-3645 | Species | denotes | patients | Tax:9606 |
1190 | 3337-3346 | Chemical | denotes | Aliskiren | MESH:C446481 |
1191 | 3279-3287 | Disease | denotes | COVID-19 | MESH:C000657245 |
1192 | 3480-3500 | Disease | denotes | diabetic nephropathy | MESH:D003928 |
1193 | 3628-3636 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T256 | 18-23 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T257 | 63-84 | Body_part | denotes | cardiovascular system | http://purl.org/sig/ont/fma/fma7161 |
T258 | 134-139 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T259 | 268-272 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T260 | 318-323 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T261 | 339-344 | Body_part | denotes | lungs | http://purl.org/sig/ont/fma/fma68877 |
T262 | 1070-1075 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T263 | 1124-1138 | Body_part | denotes | T-helper cells | http://purl.org/sig/ont/fma/fma70572 |
T264 | 1133-1138 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T265 | 1150-1158 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
T266 | 1616-1625 | Body_part | denotes | pericytes | http://purl.org/sig/ont/fma/fma63174 |
T267 | 2073-2081 | Body_part | denotes | profilin | http://purl.org/sig/ont/fma/fma67123 |
T268 | 2343-2347 | Body_part | denotes | mRNA | http://purl.org/sig/ont/fma/fma67122 |
T269 | 2584-2588 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T270 | 2688-2695 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T271 | 2796-2802 | Body_part | denotes | tissue | http://purl.org/sig/ont/fma/fma9637 |
T272 | 2919-2923 | Body_part | denotes | hand | http://purl.org/sig/ont/fma/fma9712 |
T273 | 3113-3119 | Body_part | denotes | tissue | http://purl.org/sig/ont/fma/fma9637 |
T274 | 3437-3442 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T125 | 18-23 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T126 | 63-84 | Body_part | denotes | cardiovascular system | http://purl.obolibrary.org/obo/UBERON_0004535 |
T127 | 134-139 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T128 | 318-323 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T129 | 1070-1075 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T130 | 2796-2802 | Body_part | denotes | tissue | http://purl.obolibrary.org/obo/UBERON_0000479 |
T131 | 2919-2923 | Body_part | denotes | hand | http://purl.obolibrary.org/obo/UBERON_0002398 |
T132 | 3113-3119 | Body_part | denotes | tissue | http://purl.obolibrary.org/obo/UBERON_0000479 |
T133 | 3437-3442 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T314 | 5-13 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T315 | 5-9 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T316 | 18-31 | Disease | denotes | heart disease | http://purl.obolibrary.org/obo/MONDO_0005267 |
T317 | 159-171 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T318 | 176-192 | Disease | denotes | type II diabetes | http://purl.obolibrary.org/obo/MONDO_0005148 |
T319 | 184-192 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T320 | 232-240 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T321 | 232-236 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T322 | 402-410 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T323 | 402-406 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T324 | 413-422 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T325 | 562-570 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T326 | 599-611 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T327 | 832-847 | Disease | denotes | viral infection | http://purl.obolibrary.org/obo/MONDO_0005108 |
T328 | 838-847 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T329 | 993-1001 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T330 | 993-997 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T331 | 1076-1082 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T332 | 1173-1181 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T333 | 1173-1177 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T334 | 1225-1233 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T335 | 1225-1229 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T336 | 1235-1243 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T337 | 1235-1239 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T338 | 1350-1358 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T339 | 1350-1354 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T340 | 1456-1479 | Disease | denotes | acute coronary syndrome | http://purl.obolibrary.org/obo/MONDO_0005542 |
T341 | 1563-1571 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T342 | 1654-1662 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T343 | 1654-1658 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T344 | 1686-1701 | Disease | denotes | cardiac failure | http://purl.obolibrary.org/obo/MONDO_0005252 |
T345 | 2557-2565 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T346 | 2557-2561 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T347 | 2803-2809 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T348 | 2860-2872 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T349 | 2998-3010 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T350 | 3120-3126 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T351 | 3279-3287 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T352 | 3480-3500 | Disease | denotes | diabetic nephropathy | http://purl.obolibrary.org/obo/MONDO_0005016 |
T353 | 3489-3500 | Disease | denotes | nephropathy | http://purl.obolibrary.org/obo/MONDO_0005240 |
T354 | 3628-3636 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T379 | 18-23 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T380 | 18-23 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T381 | 18-23 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T382 | 18-23 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T383 | 43-44 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T384 | 63-84 | http://purl.obolibrary.org/obo/UBERON_0004535 | denotes | cardiovascular system |
T385 | 63-84 | http://www.ebi.ac.uk/efo/EFO_0000791 | denotes | cardiovascular system |
T386 | 134-139 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T387 | 134-139 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T388 | 134-139 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T389 | 134-139 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T390 | 268-272 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T391 | 318-323 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T392 | 318-323 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T393 | 318-323 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T394 | 318-323 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T395 | 339-344 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lungs |
T396 | 357-358 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T397 | 459-462 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T398 | 921-926 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T399 | 1023-1024 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T400 | 1025-1031 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signal |
T401 | 1070-1075 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T402 | 1070-1075 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T403 | 1070-1075 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T404 | 1070-1075 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T405 | 1124-1138 | http://purl.obolibrary.org/obo/CL_0000912 | denotes | T-helper cells |
T406 | 1148-1149 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T407 | 1184-1187 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T408 | 1188-1189 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T409 | 1390-1391 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T410 | 1987-1995 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T411 | 2146-2154 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T412 | 2224-2232 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T413 | 2313-2321 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T414 | 2584-2588 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T415 | 2755-2762 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus's |
T416 | 3215-3218 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T417 | 3348-3349 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T418 | 3437-3442 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T419 | 3437-3442 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T420 | 3457-3460 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T421 | 3501-3507 | http://purl.obolibrary.org/obo/NCBITaxon_33208 | denotes | animal |
T422 | 3605-3606 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T120 | 181-183 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T121 | 512-516 | Chemical | denotes | ACEi | http://purl.obolibrary.org/obo/CHEBI_35457 |
T122 | 624-628 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T123 | 632-636 | Chemical | denotes | ACEi | http://purl.obolibrary.org/obo/CHEBI_35457 |
T124 | 651-662 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T125 | 1777-1795 | Chemical | denotes | mineralocorticoids | http://purl.obolibrary.org/obo/CHEBI_25354 |
T126 | 1908-1919 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T127 | 1943-1957 | Chemical | denotes | angiotensin II | http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506 |
T130 | 1943-1954 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T131 | 1955-1957 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T132 | 2008-2018 | Chemical | denotes | antagonist | http://purl.obolibrary.org/obo/CHEBI_48706 |
T133 | 2022-2036 | Chemical | denotes | angiotensin II | http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506 |
T136 | 2022-2033 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T137 | 2034-2036 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T138 | 2131-2145 | Chemical | denotes | angiotensin II | http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506 |
T141 | 2131-2142 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T142 | 2143-2145 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T143 | 2275-2285 | Chemical | denotes | lisinopril | http://purl.obolibrary.org/obo/CHEBI_43755 |
T144 | 2290-2298 | Chemical | denotes | losartan | http://purl.obolibrary.org/obo/CHEBI_6541 |
T145 | 2403-2417 | Chemical | denotes | angiotensin II | http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506 |
T148 | 2403-2414 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T149 | 2415-2417 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T150 | 2436-2447 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T151 | 2457-2471 | Chemical | denotes | angiotensin II | http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506 |
T154 | 2457-2468 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T155 | 2469-2471 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T156 | 2488-2498 | Chemical | denotes | antagonist | http://purl.obolibrary.org/obo/CHEBI_48706 |
T157 | 2527-2541 | Chemical | denotes | angiotensin II | http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506 |
T160 | 2527-2538 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T161 | 2539-2541 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T162 | 2688-2695 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T163 | 2879-2886 | Chemical | denotes | oxidant | http://purl.obolibrary.org/obo/CHEBI_63248 |
T164 | 2929-2943 | Chemical | denotes | angiotensin II | http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506 |
T167 | 2929-2940 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T168 | 2941-2943 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T169 | 3016-3023 | Chemical | denotes | oxidant | http://purl.obolibrary.org/obo/CHEBI_63248 |
T170 | 3180-3184 | Chemical | denotes | ACEi | http://purl.obolibrary.org/obo/CHEBI_35457 |
T171 | 3196-3214 | Chemical | denotes | mineralocorticoids | http://purl.obolibrary.org/obo/CHEBI_25354 |
T172 | 3357-3366 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T173 | 3559-3568 | Chemical | denotes | aliskiren | http://purl.obolibrary.org/obo/CHEBI_601027 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T42 | 134-155 | http://purl.obolibrary.org/obo/GO_0007507 | denotes | heart and development |
T43 | 832-847 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infection |
T44 | 1095-1110 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
T45 | 2158-2167 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
T46 | 2390-2399 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | formation |
T47 | 2422-2432 | http://purl.obolibrary.org/obo/GO_0008152 | denotes | metabolism |
T48 | 2513-2523 | http://purl.obolibrary.org/obo/GO_0008152 | denotes | metabolism |
T49 | 2860-2872 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
T50 | 2892-2904 | http://purl.obolibrary.org/obo/GO_0042311 | denotes | vasodilation |
T51 | 2998-3010 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
T52 | 3055-3071 | http://purl.obolibrary.org/obo/GO_0042310 | denotes | vasoconstriction |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T185 | 0-31 | Sentence | denotes | 6.1 SARS-CoV-2 – heart disease |
T186 | 32-193 | Sentence | denotes | ACE2 plays a vital role in the cardiovascular system and is mainly involved in the functioning of the heart and development of hypertension and type II diabetes. |
T187 | 194-423 | Sentence | denotes | Since ACE2 is the main target for the SARS-CoV-2 to enter inside the host cell and the ACE2 is also highly expressed in the heart apart from the lungs, indicating a chance of developing cardiac issues during SARS-CoV-2 infection. |
T188 | 424-557 | Sentence | denotes | The anti-hypertensive therapy that has been prescribed for the patients is the usage of ACEi and ARBs should be carefully considered. |
T189 | 558-811 | Sentence | denotes | The COVID-19 patients with comorbidities hypertension, taking the drug of ACEi or blocker of angiotensin receptor, need to switch off to other anti-hypertensive medications found to be controversial and require further studies this co-morbid conditions. |
T190 | 812-969 | Sentence | denotes | The severity of the viral infection is higher in patients with comorbidities than those infected only by the virus without any predisposed health issue [85]. |
T191 | 970-1168 | Sentence | denotes | The interaction of the SARS-CoV-2 with ACE2 triggers a signal, which might be the reason to develop heart injury through the immune response triggered by T-helper cells creating a cytokine response. |
T192 | 1169-1234 | Sentence | denotes | The SARS-CoV-2 has a structural similarity with that of SARS-CoV. |
T193 | 1235-1307 | Sentence | denotes | SARS-CoV caused severe cardiovascular damage during its pandemic period. |
T194 | 1308-1417 | Sentence | denotes | Therefore, it is essential to investigate SARS-CoV-2 treatment options and ensure a cardio-protective effect. |
T195 | 1418-1577 | Sentence | denotes | The age and the predisposition of the acute coronary syndrome are the two critical factors which need to be considered in patients affected with COVID-19 [85]. |
T196 | 1578-1763 | Sentence | denotes | Since the ACE2 is highly expressed in pericytes, the patients infected with SARS-CoV-2 and predisposed with cardiac failure are more susceptible to develop severe cardiac problems [86]. |
T197 | 1764-2109 | Sentence | denotes | The usage of mineralocorticoids receptor blocker can attenuates oxidative stress, reduces the level of ACE with the augmented production of the angiotensin 1–7 and attenuates the angiotensin II generation and increases the activity of ACE2 The antagonist of angiotensin II type 1 receptor, have modulates the profilin-1 expression and ACE2 [87]. |
T198 | 2110-2244 | Sentence | denotes | The selective of the angiotensin II activity or synthesis mediated the augmented level of ACE2 expression and its activity in cardiac. |
T199 | 2245-2348 | Sentence | denotes | Still, the combination of the lisinopril and losartan increases the activity of ACE2 but not ACE2 mRNA. |
T200 | 2349-2556 | Sentence | denotes | The inhibition of ACE results in reduced formation of angiotensin II and metabolism of angiotensin 1–7, the angiotensin II type 1 receptor antagonist increases the metabolism of angiotensin II via ACE2 [88]. |
T201 | 2557-2730 | Sentence | denotes | SARS-CoV 2 enters into the cell via the ACE2 receptor; this causes the decreased level of the ACE2 due to the binding of the spike protein to the ACE2 and no changes in ACE. |
T202 | 2731-2905 | Sentence | denotes | This process causes the virus's entry, replicates it, and causes tissue injury via decreasing anti-atrophy, anti0-fibrosis, anti-inflammation, anti-oxidant, and vasodilation. |
T203 | 2906-3157 | Sentence | denotes | On the other hand, the angiotensin II type 1 receptor causes pro-atrophy, pro-fibrosis, pro-inflammation, pro-oxidant, severe myocardial remodeling, vasoconstriction and vascular permeability which leads to tissue injury [89] (represented in Table 1). |
T204 | 3158-3336 | Sentence | denotes | Therefore, the use of ACEi, ARBs, and mineralocorticoids has shown to have an impact on the cardiac patients affected by COVID-19, but the exact mechanism behind it is not clear. |
T205 | 3337-3520 | Sentence | denotes | Aliskiren, a direct inhibitor of renin, resulted in reduced expression of ACE2 besides reducing the blood pressure that has been elucidated in diabetic nephropathy animal models [90]. |
T206 | 3521-3670 | Sentence | denotes | Therefore, renin blockers, especially aliskiren, need to be further investigated as a treatment option for COVID-19 patients with comorbidities [91]. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T138 | 159-171 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T139 | 176-192 | Phenotype | denotes | type II diabetes | http://purl.obolibrary.org/obo/HP_0005978 |
T140 | 599-611 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T141 | 816-847 | Phenotype | denotes | severity of the viral infection | http://purl.obolibrary.org/obo/HP_0031691 |
T142 | 1686-1701 | Phenotype | denotes | cardiac failure | http://purl.obolibrary.org/obo/HP_0001635 |
T143 | 1828-1844 | Phenotype | denotes | oxidative stress | http://purl.obolibrary.org/obo/HP_0025464 |
T144 | 3489-3500 | Phenotype | denotes | nephropathy | http://purl.obolibrary.org/obo/HP_0000112 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32450165-32231330-66451073 | 965-967 | 32231330 | denotes | 85 |
32450165-32231330-66451074 | 1573-1575 | 32231330 | denotes | 85 |
32450165-32227090-66451075 | 1759-1761 | 32227090 | denotes | 86 |
32450165-16179584-66451076 | 2105-2107 | 16179584 | denotes | 87 |
32450165-15897343-66451077 | 2552-2554 | 15897343 | denotes | 88 |
32450165-30554582-66451078 | 3516-3518 | 30554582 | denotes | 90 |